Le Lézard
Classified in: Health
Subject: SCZ

Independent Living Systems Announces NCQA Re-Accreditation for Case Management for Long-Term Services and Supports


MIAMI, Jan. 7, 2021 /PRNewswire/ -- Independent Living Systems ("ILS"), an industry leader in managing high-cost, complex member populations in the Medicare, Medicaid and Dual-Eligible market, announced today that it has received re-accreditation from the National Committee for Quality Assurance ("NCQA") for Case Management for Long-Term Services and Supports ("LTSS"). ILS' principled dedication to long-term care services, care management, improved outcomes, and continuous quality improvement is evidenced by this re-accreditation. ILS also holds NCQA certifications for Wellness and Health Promotion and Credential Verification Organization. ("CVO").

"Achieving NCQA accreditation again for Case Management for LTSS is a testament to the work we do every day to serve the needs of vulnerable, frail and aging populations nationwide," said Nestor Plana, Chairman/CEO of ILS. "By leveraging our award-winning care management system, we are able to continue to raise the bar and drive improved outcomes."

ILS has been NCQA-accredited for Case Management for LTSS since 2017. ILS again decided to pursue the prestigious three-year NCQA accreditation in 2020 to align with the company's commitment to enhancing quality of life by improving health outcomes, reducing costs, and addressing social determinants of health.

This accreditation helps support organizations that coordinate LTSS by providing a framework for quality improvement. NCQA's standards, which provide a framework for organizations to deliver efficient, effective person-centered care that meets people's needs, helps keep people in their preferred setting and aligns with state requirements. Accreditation focuses on conducting comprehensive assessments, managing care transitions, performing person-centered assessments and care planning, managing critical incident, and measurement and quality improvement.

Click here to view ILS' NCQA certificate. For complete details on the scope of NCQA accreditation, visit www.ncqa.org.

About Independent Living Systems:

Independent Living Systems ("ILS") is a Florida-based health care services company that provides a range of health care management services on behalf of health care plans, health systems, providers, and community-based organizations. ILS provides member-centric health and support solutions to millions of America's Medicare, Medicaid, dually eligible, and Special Needs populations including those requiring Long-Term Services and Supports. For more information, visit www.ilshealth.com.

About NCQA:

NCQA is an independent, not-for-profit organization dedicated to assessing and reporting on the quality of managed care plans, managed behavioral healthcare organizations, preferred provider organizations, new health plans, physician organizations, credentials verification organizations, disease management programs and other health-related programs. For more information, visit www.ncqa.org.

Media Contact

Mari Netto

VP Marketing, ILS

[email protected]

SOURCE Independent Living Systems


These press releases may also interest you

at 03:00
ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs, today announced an oral presentation at the upcoming Oligonucleotide & Peptide Therapeutics (TIDES) Conference...

at 02:32
With every successive year, the lines between medical devices and consumer electronics become increasingly blurred ? medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications...

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...



News published on and distributed by: